Comerica Bank’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Comerica Bank’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$31.1K	Buy	378 +175	+86%	+$13.5K	﹤0.01%	2999
2025 Q3	$14.2K	Hold	203	–	–	﹤0.01%	3179
2025 Q2	$13K	Hold	203	–	–	﹤0.01%	3154
2025 Q1	$12.9K	Hold	203	–	–	﹤0.01%	3121
2024 Q4	$13.5K	Hold	203	–	–	﹤0.01%	3124
2024 Q3	$14.2K	Sell	203 -50	-20%	-$3.46K	﹤0.01%	3108
2024 Q2	$16.4K	Buy	253 +16	+7%	+$1.01K	﹤0.01%	3050
2024 Q1	$15.3K	Sell	237 -169	-42%	-$11K	﹤0.01%	3095
2023 Q4	$26.7K	Sell	406 -100	-20%	-$5.81K	﹤0.01%	2897
2023 Q3	$28.9K	Buy	+506	New	+$30.9K	﹤0.01%	2880

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Comerica Bank's PBE Position: Q4 2025 in Review

Comerica Bank increased its Invesco Biotechnology & Genome ETF (PBE) stake by 86% in Q4 2025, buying an estimated $13.5K and bringing the position to 378 shares worth $31.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2999.

Comerica Bank first reported a position in PBE in Q3 2023 and has held it in 10 quarters since. 108 funds tracked by Wall St. Rank hold PBE as of Q4 2025.

Comerica Bank held 378 shares of Invesco Biotechnology & Genome ETF worth $31.1K as of Q4 2025.
Comerica Bank bought 175 Invesco Biotechnology & Genome ETF shares in Q4 2025, an estimated $13.5K.
Invesco Biotechnology & Genome ETF made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2999 holding.
Comerica Bank first reported a position in Invesco Biotechnology & Genome ETF in Q3 2023 and has held it in 10 quarters since.
108 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.